ObjectiveThis study aimed to explore the underlying mechanism of Batri-7 in tubal inflammatory infertility model rats treatment in the toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88)/nuclear factor kappa B (NF-κB) pathway.MethodsFifty-three specific-pathogen-free-grade female Sprague–Dawley rats were selected, of which 10 were randomly assigned to the blank control group (normal rats). The remaining 43 rats were used to establish a salpingitis model, induced by mixed bacteria, and were randomly divided into a model group, a positive control group, a low-dose experimental group and a high-dose experimental group.
The rats in the blank and model groups were gavaged with 10 mL·kg-1·d-1 distilled water, a Jingangteng Capsules suspension (0.4 g·kg-1) was used for the positive control group and a high-dose (0.5g·kg-1) and low-dose (0.3g·kg-1) once a day was used for the treatment groups. The rats were sacrificed after 28 days, and the fallopian tube tissue was collected after blood collection from the abdominal aorta.
The contents of interleukin-1 beta (IL-1β), interleukin-10 (IL-10), intercellular adhesion molecule-1 (ICAM-1) and tumour necrosis factor-alpha (TNF-α) in plasma were detected by enzyme-linked immunosorbent assay.
Frontiers in Immunology published a clinical update in Infectious Disease on 20 Apr 2026.
The item focuses on Effects of Batri-7 on fallopian tube tissues in a rat model of salpingitis based on the toll-like receptor 4/myeloid differentiation factor 88/nuclear factor kappa B signalling pathway.
Review the original article for the full source wording and details.